Thirty five years ago, we launched Wall Street's premier investor conference focused exclusively on companies defining the healthcare industry. Today, the J.P. Morgan Healthcare Conference continues our tradition of hosting the largest and most informative healthcare...
Michael O’Rourke presents Re-Vana Therapeutics – ‘Companies to Watch’ at the Ophthalmic Innovation Summit 2017. https://ois.net/companies-watch-re-vana-therapeutics//
Re-Vana Therapeutics agree research collaboration with Nicox. http://www.nicox.com/assets/files/Nicox-ReVana-Press-Release-_EN_FINAL.pdf
Michael J. O’Rourke, CEO, presented Re-Vana Therapeutics at the Ophthalmology Future Forum 2017, Thursday 05 October, Myriad Crystal Center, Lisbon, Portugal.
Re-Vana will attend the retina and drug delivery focused OIS in Boston, 12th August 2017 and the Ophthalmology Futures Meeting in Lisbon, Portugal 5th October 2017.
Watch CEO Michael O’Rourke being interviewed on Re-Vana technology for the Syndicate Room, London, June 22nd 2017. https://www.youtube.com/watch?v=rQ1sjcUAOhg
Re-Vana attended the Ophthalmic Innovation Summit (OIS) Meeting in Los Angeles and ARVO in Baltimore, Maryland, May 2017.